Iterum Therapeutics PLC ITRMF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.83
- Bid/Ask
- $0.00 / $2,000.00
- Shares Outstanding
- 53.29M
- Market Cap
- $53.29
- Volume/Avg
- 1,736 / 63,904
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 9
- Website
- https://www.iterumtx.com
Valuation
|
Metric
|
ITRMF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ITRMF
|
|---|---|
Quick Ratio | 1.80 |
Current Ratio | 2.13 |
Interest Coverage | −11.33 |
Quick Ratio
ITRMF
Profitability
|
Metric
|
ITRMF
|
|---|---|
Return on Assets (Normalized) | −58.77% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −61.79% |
Return on Assets
ITRMF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|KSxRp& | LOCK|!g^% | $133B | |||
| Moderna Inc
MRNA
| LOCK|#C?tVZ | LOCK|jbR | $98B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|kCl#^Ny | LOCK|s!>^! | $83B | |||
| argenx SE ADR
ARGX
| LOCK|y!^qmC | LOCK|$T | $56B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|%Hsh!ky | LOCK|k<l | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|RmnXBJT | LOCK|FlcD | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|bFDDR>>< | LOCK|vKx%H | $28B | |||
| Incyte Corp
INCY
| LOCK|MFZ^QPr | LOCK|zx | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|%#<D<t | LOCK|j$@ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|B%xbw^Z | LOCK|QY | $14B |
United States